My NCBISign In
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerød, Hongjuan Zhao, Ørnulf Borgan, Jahn M Nesland, Ida RK Bukholm, Tone Ikdahl, Rolf Kåresen, Anne-Lise Børresen-Dale, Stefanie S Jeffrey
Breast Cancer Res. 2007; 9(3): R30. Published online 2007 May 15. doi: 10.1186/bcr1675
PMCID:
PMC1929092
Abstract Full Text PDF–2.2M Supplementary Material

Is Cited by the Following 34 Articles in this Archive:

Basal Breast Cancer: A Complex and Deadly Molecular Subtype
F Bertucci, P Finetti, D Birnbaum
Curr Mol Med. 2012 January; 12(1): 96–110. Published online 2012 January. doi: 10.2174/156652412798376134
PMCID:
PMC3343384
Abstract Full Text PDF–871K
Patient-Specific Data Fusion Defines Prognostic Cancer Subtypes
Yinyin Yuan, Richard S. Savage, Florian Markowetz
PLoS Comput Biol. 2011 October; 7(10): e1002227. Published online 2011 October 20. doi: 10.1371/journal.pcbi.1002227
PMCID:
PMC3197649
Abstract Full Text PDF–2.4M
Insight into the heterogeneity of breast cancer through next-generation sequencing
Hege G. Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale
J Clin Invest. 2011 October 3; 121(10): 3810–3818. Published online 2011 October 3. doi: 10.1172/JCI57088
PMCID:
PMC3195464
Abstract Full Text PDF–1.6M
Up-Regulation of Kin17 Is Essential for Proliferation of Breast Cancer
Tao Zeng, Hongyi Gao, Pei Yu, Heng He, Xiaoming Ouyang, Lijuan Deng, Yan Zhang
PLoS One. 2011; 6(9): e25343. Published online 2011 September 29. doi: 10.1371/journal.pone.0025343
PMCID:
PMC3183049
Abstract Full Text PDF–778K Supplementary Material
Invasive Breast Cancer: Recognition of Molecular Subtypes
Johanna D. Strehl, David L. Wachter, Peter A. Fasching, Matthias W. Beckmann, Arndt Hartmann
Breast Care (Basel) 2011 August; 6(4): 258–264. Published online 2011 August 26. doi: 10.1159/000331339
PMCID:
PMC3225209
Free in PMC on 2012/08/01
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer
Tasha R. Smith, Wen Liu-Mares, Beth O. Van Emburgh, Edward A. Levine, Glenn O. Allen, Jeff W. Hill, Isildinha M. Reis, Laura A. Kresty, Mark D. Pegram, Mark S. Miller, Jennifer J. Hu
Carcinogenesis. 2011 September; 32(9): 1354–1360. Published online 2011 June 23. doi: 10.1093/carcin/bgr117
PMCID:
PMC3165125
Free in PMC on 2012/09/01
Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival
Monica Nicolau, Arnold J. Levine, Gunnar Carlsson
Proc Natl Acad Sci U S A. 2011 April 26; 108(17): 7265–7270. Published online 2011 April 11. doi: 10.1073/pnas.1102826108
PMCID:
PMC3084136
Abstract Full Text PDF–342K Supplementary Material
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Benjamin T. Spike, Geoffrey M. Wahl
Genes Cancer. 2011 April; 2(4): 404–419. doi: 10.1177/1947601911410224
PMCID:
PMC3135646
Abstract Full Text PDF–525K
Combining Gene Signatures Improves Prediction of Breast Cancer Survival
Xi Zhao, Einar Andreas Rødland, Therese Sørlie, Bjørn Naume, Anita Langerød, Arnoldo Frigessi, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Ole Christian Lingjærde
PLoS One. 2011; 6(3): e17845. Published online 2011 March 10. doi: 10.1371/journal.pone.0017845
PMCID:
PMC3053398
Abstract Full Text PDF–1.6M Supplementary Material
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Espen Enerly, Israel Steinfeld, Kristine Kleivi, Suvi-Katri Leivonen, Miriam R. Aure, Hege G. Russnes, Jo Anders Rønneberg, Hilde Johnsen, Roy Navon, Einar Rødland, Rami Mäkelä, Bjørn Naume, Merja Perälä, Olli Kallioniemi, Vessela N. Kristensen, Zohar Yakhini, Anne-Lise Børresen-Dale
PLoS One. 2011; 6(2): e16915. Published online 2011 February 22. doi: 10.1371/journal.pone.0016915
PMCID:
PMC3043070
Abstract Full Text PDF–2.7M Supplementary Material
Systems Biology and Genomics of Breast Cancer
Charles M. Perou, Anne-Lise Børresen-Dale
Cold Spring Harb Perspect Biol. 2011 February; 3(2): a003293. doi: 10.1101/cshperspect.a003293
PMCID:
PMC3039533
Free in PMC on 2013/02/01
Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures
Hideaki Mizuno, Benjamin T. Spike, Geoffrey M. Wahl, Arnold J. Levine
Proc Natl Acad Sci U S A. 2010 December 28; 107(52): 22745–22750. Published online 2010 December 13. doi: 10.1073/pnas.1017001108
PMCID:
PMC3012457
Abstract Full Text PDF–1.3M Supplementary Material
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
Henne Holstege, Hugo M Horlings, Arno Velds, Anita Langerød, Anne-Lise Børresen-Dale, Marc J van de Vijver, Petra M Nederlof, Jos Jonkers
BMC Cancer. 2010; 10: 654. Published online 2010 November 30. doi: 10.1186/1471-2407-10-654
PMCID:
PMC3002929
Abstract Full Text PDF–1.3M Supplementary Material
Systematical Detection of Significant Genes in Microarray Data by Incorporating Gene Interaction Relationship in Biological Systems
Junwei Wang, Meiwen Jia, Liping Zhu, Zengjin Yuan, Peng Li, Chang Chang, Jian Luo, Mingyao Liu, Tieliu Shi
PLoS One. 2010; 5(10): e13721. Published online 2010 October 29. doi: 10.1371/journal.pone.0013721
PMCID:
PMC2966410
Abstract Full Text PDF–851K Supplementary Material
Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
Daniel J. Toft, Vincent L. Cryns
Mol Endocrinol. 2011 February; 25(2): 199–211. Published online 2010 September 22. doi: 10.1210/me.2010-0164
PMCID:
PMC3035993
Abstract Full Text
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
Yi-Ping Fu, Hege Edvardsen, Alpana Kaushiva, Juan P Arhancet, Tiffany M Howe, Indu Kohaar, Patricia Porter-Gill, Anushi Shah, Hege Landmark-Høyvik, Sophie D Fosså, Stefan Ambs, Bjørn Naume, Anne-Lise Børresen-Dale, Vessela N Kristensen, Ludmila Prokunina-Olsson
Mol Cancer. 2010; 9: 113. Published online 2010 May 19. doi: 10.1186/1476-4598-9-113
PMCID:
PMC2887795
Abstract Full Text PDF–1.2M Supplementary Material
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation
Jennifer J. Jordan, Alberto Inga, Kathleen Conway, Sharon Edmiston, Lisa A. Carey, Lin Wu, Michael A. Resnick
Mol Cancer Res. Author manuscript; available in PMC 2011 May 1.
Published in final edited form as: Mol Cancer Res. 2010 May; 8(5): 701–716. Published online 2010 April 20. doi: 10.1158/1541-7786.MCR-09-0442
PMCID:
PMC2873663
Abstract Full Text PDF–809K Supplementary Material
Genomic instability in breast cancer: pathogenesis and clinical implications
Kevin A. Kwei, Yvonne Kung, Keyan Salari, Ilona N. Holcomb, Jonathan R. Pollack
Mol Oncol. Author manuscript; available in PMC 2011 June 1.
Published in final edited form as: Mol Oncol. 2010 June; 4(3): 255–266. Published online 2010 April 9. doi: 10.1016/j.molonc.2010.04.001
PMCID:
PMC2904860
Abstract Full Text PDF–1.6M
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Ana I. Robles, Curtis C. Harris
Cold Spring Harb Perspect Biol. 2010 March; 2(3): a001016. doi: 10.1101/cshperspect.a001016
PMCID:
PMC2829964
Abstract Full Text PDF–2.1M
Epithelial-Stromal Interaction 1 (EPSTI1) Substitutes for Peritumoral Fibroblasts in the Tumor Microenvironment
Michala de Neergaard, Jiyoung Kim, René Villadsen, Agla J. Fridriksdottir, Fritz Rank, Vera Timmermans-Wielenga, Anita Langerød, Anne-Lise Børresen-Dale, Ole W. Petersen, Lone Rønnov-Jessen
Am J Pathol. 2010 March; 176(3): 1229–1240. doi: 10.2353/ajpath.2010.090648
PMCID:
PMC2832145
Abstract Full Text PDF–1.5M
Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation
Jay P. Reddy, Sirisha Peddibhotla, Wen Bu, Jing Zhao, Svasti Haricharan, Yi-Chieh Nancy Du, Katrina Podsypanina, Jeffrey M. Rosen, Larry A. Donehower, Yi Li
Proc Natl Acad Sci U S A. 2010 February 23; 107(8): 3728–3733. Published online 2010 February 3. doi: 10.1073/pnas.0910665107
PMCID:
PMC2840493
Abstract Full Text PDF–1.0M Supplementary Material
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier, Monica Hollstein, Pierre Hainaut
Cold Spring Harb Perspect Biol. 2010 January; 2(1): a001008. doi: 10.1101/cshperspect.a001008
PMCID:
PMC2827900
Abstract Full Text PDF–834K
hCLCA2 is a p53-inducible inhibitor of breast cancer cell proliferation
Vijay Walia, Ming Ding, Sumit Kumar, Daotai Nie, Louis Premkumar, Randolph C. Elble
Cancer Res. Author manuscript; available in PMC 2010 August 15.
Published in final edited form as: Cancer Res. 2009 August 15; 69(16): 6624–6632. Published online 2009 August 4. doi: 10.1158/0008-5472.CAN-08-4101
PMCID:
PMC2745301
Abstract Full Text PDF–2.4M Supplementary Material
MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer
Pankaj Taneja, Donna P Frazier, Robert D Kendig, Dejan Maglic, Takayuki Sugiyama, Fumitake Kai, Neetu K Taneja, Kazushi Inoue
Expert Rev Mol Diagn. Author manuscript; available in PMC 2010 May 1.
Published in final edited form as: Expert Rev Mol Diagn. 2009 July; 9(5): 423–440. doi: 10.1586/ERM.09.31
PMCID:
PMC2759974
Abstract Full Text PDF–1.4M
Triple negative breast carcinoma is a prognostic factor in Taiwanese women
Che Lin, Su-Yu Chien, Li-Sheng Chen, Shou-Jen Kuo, Tsai-Wang Chang, Dar-Ren Chen
BMC Cancer. 2009; 9: 192. Published online 2009 June 18. doi: 10.1186/1471-2407-9-192
PMCID:
PMC2706258
Abstract Full Text PDF–297K
A signature-based method for indexing cell cycle phase distribution from microarray profiles
Hideaki Mizuno, Yoshito Nakanishi, Nobuya Ishii, Akinori Sarai, Kunio Kitada
BMC Genomics. 2009; 10: 137. Published online 2009 March 30. doi: 10.1186/1471-2164-10-137
PMCID:
PMC2676301
Abstract Full Text PDF–487K Supplementary Material
MDM2 Expression and Regulation in Prostate Cancer Racial Disparity
Guimin Wang, Elnaz F. Firoz, Amy Rose, Elen Blochin, Paul Christos, Danuta Pollens, Madhu Mazumdar, William Gerald, Carole Oddoux, Peng Lee, Iman Osman
Int J Clin Exp Pathol. 2009; 2(4): 353–360. Published online 2008 December 4.
PMCID:
PMC2615592
Abstract Full Text PDF–570K
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer
Anna Bergamaschi, Young H. Kim, Kevin A. Kwei, Yoon La Choi, Melanie Bocanegra, Anita Langerod, Wonshik Han, Dong-Young Noh, David G. Huntsman, Stefanie S. Jeffrey, Anne-Lise Borresen-Dale, Jonathan R. Pollack
Mol Oncol. Author manuscript; available in PMC 2009 December 1.
Published in final edited form as: Mol Oncol. 2008 December 1; 2(4): 327–339. doi: 10.1016/j.molonc.2008.09.004
PMCID:
PMC2653212
Abstract Full Text PDF–2.9M
Regulation of cancer stem cells by p53
D Joseph Jerry, Luwei Tao, Haoheng Yan
Breast Cancer Res. 2008; 10(4): 304. Published online 2008 August 29. doi: 10.1186/bcr2133
PMCID:
PMC2575544
Abstract Full Text PDF–405K
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Amanda I. Phipps, Kathleen E. Malone, Peggy L. Porter, Janet R. Daling, Christopher I. Li
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2009 August 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 August; 17(8): 2078–2086. Published online 2008 July 29. doi: 10.1158/1055-9965.EPI-08-0206
PMCID:
PMC2561180
Abstract Full Text PDF–332K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk